Barclays
GERN icon

Barclays’s Geron GERN Stock Holding History

Barclays’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-88,400
Closed -$156K – 7068
2018
Q3 		$156K Buy
88,400
+40,500
+85% +$177K ﹤0.01% 5193
2018
Q2 		$164K Buy
+47,900
New +$183K ﹤0.01% 4879
2018
Q1 		– Sell
-2,000
Closed -$4K – 7156
2017
Q4 		$4K Sell
2,000
-21,800
-92% -$44K ﹤0.01% 6694
2017
Q3 		$52K Sell
23,800
-8,000
-25% -$18.9K ﹤0.01% 5331
2017
Q2 		$88K Buy
31,800
+22,400
+238% +$59.5K ﹤0.01% 5001
2017
Q1 		$21K Sell
9,400
-13,600
-59% -$29K ﹤0.01% 5786
2016
Q4 		$48K Sell
23,000
-8,800
-28% -$18.6K ﹤0.01% 5185
2016
Q3 		$72K Buy
31,800
+29,400
+1,225% +$76.2K ﹤0.01% 4745
2016
Q2 		$6K Sell
2,400
-93,600
-98% -$272K ﹤0.01% 5699
2016
Q1 		$192K Buy
96,000
+92,000
+2,300% +$275K ﹤0.01% 3877
2015
Q4 		$16K Buy
4,000
+200
+5% +$803 ﹤0.01% 5261
2015
Q3 		$8K Sell
3,800
-9,000
-70% -$32.6K ﹤0.01% 5865
2015
Q2 		$51K Sell
12,800
-14,300
-53% -$56.7K ﹤0.01% 5126
2015
Q1 		$81K Buy
27,100
+2,700
+11% +$9.17K ﹤0.01% 4974
2014
Q4 		$73K Buy
24,400
+14,800
+154% +$41K ﹤0.01% 5430
2014
Q3 		$19K Sell
9,600
-15,369
-62% -$37.9K ﹤0.01% 6509
2014
Q2 		$71K Sell
24,969
-34,279
-58% -$71.6K ﹤0.01% 5696
2014
Q1 		$112K Buy
59,248
+41,156
+227% +$164K ﹤0.01% 5343
2013
Q4 		$68K Sell
18,092
-21,477
-54% -$92.1K ﹤0.01% 5962
2013
Q3 		$112K Buy
39,569
+27,085
+217% +$44.4K ﹤0.01% 5532
2013
Q2 		$18K Buy
+12,484
New +$13.6K ﹤0.01% 6877

Other funds holding GERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's GERN Position: Q2 2026 in Review

Barclays reduced its Geron (GERN) stake by 44% in Q2 2026, selling an estimated $128K and leaving 115,240 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #3875.

Barclays first reported a position in GERN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.9M in Q3 2024. 260 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Barclays held 115,240 shares of Geron worth $148K as of Q2 2026.
  • Barclays sold 90,727 Geron shares in Q2 2026, an estimated $128K.
  • Geron made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3875 holding.
  • Barclays first reported a position in Geron in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Geron position peaked at $5.9M in Q3 2024.
  • 260 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.